Pharma Stocks Outlook: 10 - 14.09.2012



Mid-cap pharmaceutical stocks are seen gaining this week while large-caps are expected to trade in a narrow range due to lack of any major positive trigger. Most mid-cap stocks have been flat for the past few weeks and should have a good run this week. In case of large-cap stocks, most of them had a rally this week, they are expected to be range-bound this week with a negative bias. Among mid-cap stocks, Ajanta Pharma, Jubilant Life Sciences, Shasun Pharmaceuticals, and Torrent Pharmaceuticals look positive for this week.

Investor sentiment in the Shasun Pharma counter is seen positive as the company is expected to bag an overseas contract this week. In large-caps, Ranbaxy Laboratories Ltd may rise ahead of the launch of its anti-diabetic drug Diovan later this month. Talking about Lupin, he said the management looks upbeat at present, which is very positive for investors. Panacea Biotec yesterday said it would Tuesday announce a strategic collaboration with US-based Osmotica Pharmaceuticals.

www.rupeedesk.in

DISCLAIMER

The suggestions made herein are for information purposes and are not recommendations to any person to buy or sell any securities. The information is derived from various sources that are deemed to be reliable but its accuracy and completeness are not guaranteed.Our blog does not accept any liability for the use of this column. Readers of this column who buy or sell securities based on the information in this column are solely responsible for their actions. And we won't be liable or responsible for any legal or financial losses made by anyone .Any surfing and reading of the information available in this blog is the acceptance of this disclaimer.